...
首页> 外文期刊>Vaccine >Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production
【24h】

Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production

机译:悬浮MDCK细胞的半灌注培养使高细胞浓度和有效的流感病毒产生

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Control and prevention of rapid influenza spread among humans depend on the availability of efficient and safe seasonal and pandemic vaccines, made primarily from inactivated influenza virus particles. Current influenza virus production processes rely heavily on embryonated chicken eggs or on cell culture as substrate for virus propagation. Today's efforts towards process intensification in animal cell culture could innovate viral vaccine manufacturing using high-yield suspension cells in high cell density perfusion processes. In this work, we present a MDCK cell line adapted to grow as single cell suspension with a doubling time of less than 20 h, achieving cell concentrations over 1 x 10(7) cells/mL in batch mode. Influenza A virus titer obtained in batch infections were 3.6 log(10)(HAU/100 mu L) for total- and 10(9) virions/mL for infectious virus particles (TCID50), respectively. In semi-perfusion mode concentrations up to 6 x 10(7) cells/mL, accumulated virus titer of 4.5 log(10)(HAU/100 mu L) aud infectious titer of almost 10(10 )virions/mL (TCID50) were possible. This exceeds results reported previously for cell culture-based influenza virus propagation by far and suggests perfusion cultures as the preferred method in viral vaccine manufacturing. (C) 2019 Published by Elsevier Ltd.
机译:控制和预防人类蔓延的快速流感差异取决于有效和安全的季节性和大流行疫苗的可用性,主要来自灭活的流感病毒颗粒。目前的流感病毒生产过程严重依赖于胚胎鸡蛋或细胞培养作为病毒繁殖的基材。今天对动物细胞培养过程中的过程强化的努力可以在高温密度灌注过程中使用高产悬浮细胞创新病毒疫苗制造。在这项工作中,我们提出了一种适于作为单细胞悬浮液的单细胞悬浮液的MDCK细胞系,其倍数小于20小时,以批速模式实现细胞浓度超过1×10(7)个细胞/ mL。流感分批感染中获得的病毒滴度为3.6个Log(10)(Hau /100μl),分别为传染病颗粒(Tcid50)的总-10(9)个病毒粒子/ ml。在半灌注模式浓度高达6×10(7)个细胞/ ml,累积病毒滴度为4.5伐(10)(HAU /100μl)差别10(10)个病毒粒子/ ml(TCID50)是可能的。这超过了以前报告的结果,对于基于细胞培养的流感病毒繁殖,并表明灌注培养为病毒疫苗制造中的优选方法。 (c)2019年由elestvier有限公司发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号